
Akili, Inc. – NASDAQ:AKLI
Akili stock price today
Akili stock price monthly change
Akili stock price quarterly change
Akili stock price yearly change
Akili key metrics
Market Cap | 34.09M |
Enterprise value | N/A |
P/E | -2.68 |
EV/Sales | -17.35 |
EV/EBITDA | 0.17 |
Price/Sales | 113.87 |
Price/Book | 0.39 |
PEG ratio | 0.02 |
EPS | -0.61 |
Revenue | 1.94M |
EBITDA | -52.26M |
Income | -48.54M |
Revenue Q/Q | 238.93% |
Revenue Y/Y | 426.48% |
Profit margin | -10283.71% |
Oper. margin | -28667.79% |
Gross margin | -39.02% |
EBIT margin | -28667.79% |
EBITDA margin | -2683.11% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAkili stock price history
Akili stock forecast
Akili financial statements
Jun 2023 | 114K | -11.75M | -10314.91% |
---|---|---|---|
Sep 2023 | 702K | -15.87M | -2261.54% |
Dec 2023 | 749K | -11.14M | -1488.25% |
Mar 2024 | 383K | -9.76M | -2549.09% |
Sep 2025 | 1.5M | -9.39M | -626.48% |
---|---|---|---|
Oct 2025 | 1.5M | -9.42M | -628.21% |
Dec 2025 | 1.6M | -9.42M | -588.95% |
Mar 2026 | 1.82M | -9.42M | -517.76% |
Analysts Price target
Financials & Ratios estimates
2023-03-07 | -0.27 | -0.56 |
---|---|---|
2023-05-12 | -0.18 | -0.18 |
2023-08-10 | -0.2 | -0.16 |
2023-11-09 | -0.22 | -0.2 |
Jun 2023 | 111463000 | 28.5M | 25.57% |
---|---|---|---|
Sep 2023 | 93142000 | 24.04M | 25.82% |
Dec 2023 | 80383000 | 21.85M | 27.18% |
Mar 2024 | 67365000 | 17.15M | 25.47% |
Jun 2023 | -11.58M | -19.36M | -647K |
---|---|---|---|
Sep 2023 | -18.04M | 37.49M | -1.91M |
Dec 2023 | -9.13M | 12.37M | -1.88M |
Mar 2024 | -9.99M | -230K | -1.88M |
Akili alternative data
Aug 2023 | 114 |
---|---|
Sep 2023 | 111 |
Oct 2023 | 111 |
Nov 2023 | 111 |
Dec 2023 | 66 |
Jan 2024 | 66 |
Feb 2024 | 66 |
Mar 2024 | 68 |
Apr 2024 | 68 |
May 2024 | 68 |
Jun 2024 | 68 |
Jul 2024 | 68 |
Akili other data
Period | Buy | Sel |
---|---|---|
Sep 2023 | 0 | 6041 |
Quarter | Transcript |
---|---|
Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 13 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q4 2022 10 Mar 2023 | Q4 2022 Earnings Call Transcript |
Q3 2022 13 Nov 2022 | Q3 2022 Earnings Call Transcript |
-
What's the price of Akili stock today?
One share of Akili stock can currently be purchased for approximately $0.43.
-
When is Akili's next earnings date?
Unfortunately, Akili's (AKLI) next earnings date is currently unknown.
-
Does Akili pay dividends?
No, Akili does not pay dividends.
-
How much money does Akili make?
Akili has a market capitalization of 34.09M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 419.5% to 1.68M US dollars. Akili made a loss 59.49M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.
-
What is Akili's stock symbol?
Akili, Inc. is traded on the NASDAQ under the ticker symbol "AKLI".
-
What is Akili's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Akili?
Shares of Akili can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Akili have?
As Jul 2024, Akili employs 68 workers.
-
When Akili went public?
Akili, Inc. is publicly traded company for more then 4 years since IPO on 30 Jun 2021.
-
What is Akili's official website?
The official website for Akili is akiliinteractive.com.
-
Where are Akili's headquarters?
Akili is headquartered at 125 Broad Street, Boston, MA.
-
How can i contact Akili?
Akili's mailing address is 125 Broad Street, Boston, MA and company can be reached via phone at +61 74560597.
Akili company profile:

Akili, Inc.
akiliinteractive.comNASDAQ
68
Medical - Healthcare Information Services
Healthcare
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Boston, MA 02110
CIK: 0001850266
ISIN: US00974B1070
CUSIP: 00974B107